JUNO THERAPEUTICS
Juno is a clinical-stage company that brings together three of the worldโs leading cancer centers โ Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and Seattle Childrenโs Research Institute โ in unique partnership to advance a broad pipeline of breakthrough immunotherapies. With one of the largest ever Series A investments for a biotech startup, Juno will build on the foundation of novel immunotherapies to develop two distinct and complementary platforms โ CARs and TCRs.
JUNO THERAPEUTICS
Industry:
Biotechnology Clinical Trials Health Care Medical Therapeutics
Founded:
2013-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.junotherapeutics.com
Total Employee:
251+
Status:
Active
Contact:
+1 206-696-0703
Email Addresses:
[email protected]
Total Funding:
310 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail IPv6 Microsoft Azure DNS DoubleClick.Net Amazon Virginia Region Amazon Route 53
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2016-07-14 | RedoxTherapies | RedoxTherapies acquired by Juno Therapeutics | N/A |
2016-06-22 | Contura | Contura acquired by Juno Therapeutics | N/A |
2016-01-11 | AbVitro | AbVitro acquired by Juno Therapeutics | 125 M USD |
2015-06-02 | X BODY | X BODY acquired by Juno Therapeutics | 44 M USD |
2015-05-12 | Stage Cell Therapeutics | Stage Cell Therapeutics acquired by Juno Therapeutics | 22 M USD |
Investors List
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Juno Therapeutics
Bezos Expeditions
Bezos Expeditions investment in Series B - Juno Therapeutics
Venrock
Venrock investment in Series B - Juno Therapeutics
Alaska Permanent Fund
Alaska Permanent Fund investment in Series B - Juno Therapeutics
Venrock
Venrock investment in Series A - Juno Therapeutics
Bezos Expeditions
Bezos Expeditions investment in Series A - Juno Therapeutics
Alaska Permanent Fund
Alaska Permanent Fund investment in Series A - Juno Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series A - Juno Therapeutics
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2020-06-11 | JW Therapeutics | Juno Therapeutics investment in Series B - JW Therapeutics | 100 M USD |
2018-03-07 | JW Therapeutics | Juno Therapeutics investment in Series A - JW Therapeutics | 90 M USD |
2015-05-27 | Editas Medicine | Juno Therapeutics investment in Funding Round - Editas Medicine | 47 M USD |
Newest Events participated
Official Site Inspections
http://www.junotherapeutics.com
- Host name: 165.89.235.72
- IP address: 165.89.235.72
- Location: Trenton United States
- Latitude: 40.2187
- Longitude: -74.7404
- Metro Code: 504
- Timezone: America/New_York
- Postal: 08629